Psr Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -5.29%
(FY 2023)
- Profit -20.66%
(FY 2023)
- Ebitda 97.75%
(FY 2023)
- Net Worth 23.06%
(FY 2023)
- Total Assets 48.22%
(FY 2023)
About Psr Diagnostic
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mool Sharma, Sudha Sharma, and Rajeev Sharma serve as directors at the Company.
- CIN/LLPIN
U52602DL2009PTC192788
- Company No.
192788
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Psr Diagnostic Private Limited offer?
Psr Diagnostic Private Limited offers a wide range of products and services, including Analyzers & Analytical Instruments, Elemental Analyzer, Medical Laboratory Instruments, Biochemistry Analyzer, Pathology Lab Equipments, Hematology Analyzers, IVDs & Analyzers, Oxygen Concentrator, Portable Oxygen Concentrator.
Who are the key members and board of directors at Psr Diagnostic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mool Sharma  | Director | 03-Aug-2009 | Current |
| Sudha Sharma | Director | 01-May-2012 | Current |
| Rajeev Sharma | Director | 03-Aug-2009 | Current |
Financial Performance of Psr Diagnostic.
Psr Diagnostic Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.29% decrease. The company also saw a substantial fall in profitability, with a 20.66% decrease in profit. The company's net worth Soared by an impressive increase of 23.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Psr Diagnostic?
In 2023, Psr Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Finova Healthcare Private LimitedActive 7 years 7 monthsMool Sharma, Sudha Sharma and 1 more are mutual person
Finops Healthcare Private LimitedActive 11 months 3 daysSudha Sharma and Rajeev Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Psr Diagnostic?
Psr Diagnostic has a workforce of 16 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Psr Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Psr Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
